{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:54:46Z","timestamp":1790924086380,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-06269-8","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:39:00Z","timestamp":1783568340000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tirzepatide and risk of newly diagnosed aortic stenosis in patients with obesity: a multi-institutional real-world cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Jheng-Yan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keng-Wei","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Chi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsuan-Yuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1723-828X","authenticated-orcid":false,"given":"Yu-Min","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"issue":"11","key":"6269_CR1","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1161\/CIRCULATIONAHA.114.012906","volume":"131","author":"A Martinsson","year":"2015","unstructured":"Martinsson A, Li X, Andersson C, Nilsson J, Smith JG, Sundquist K. Temporal trends in the incidence and prognosis of aortic stenosis: a nationwide study of the Swedish population. Circulation. 2015;131(11):988\u201394.","journal-title":"Circulation"},{"issue":"11","key":"6269_CR2","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.jacc.2013.05.015","volume":"62","author":"RL Osnabrugge","year":"2013","unstructured":"Osnabrugge RL, Mylotte D, Head SJ, Van Mieghem NM, Nkomo VT, LeReun CM, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013;62(11):1002\u201312.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"6269_CR3","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jcmg.2009.01.004","volume":"2","author":"P Pibarot","year":"2009","unstructured":"Pibarot P, Dumesnil JG. Aortic stenosis: look globally, think globally. JACC Cardiovasc Imaging. 2009;2(4):400\u20133.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"11","key":"6269_CR4","doi-asserted-by":"publisher","first-page":"409","DOI":"10.20452\/pamw.1103","volume":"121","author":"M Olszowska","year":"2011","unstructured":"Olszowska M. Pathogenesis and pathophysiology of aortic valve stenosis in adults. Pol Arch Med Wewn. 2011;121(11):409\u201313.","journal-title":"Pol Arch Med Wewn"},{"issue":"6","key":"6269_CR5","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.numecd.2015.02.001","volume":"25","author":"V Parisi","year":"2015","unstructured":"Parisi V, Leosco D, Ferro G, Bevilacqua A, Pagano G, de Lucia C, et al. The lipid theory in the pathogenesis of calcific aortic stenosis. Nutr Metab Cardiovasc Dis. 2015;25(6):519\u201325.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"10","key":"6269_CR6","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.acvd.2023.07.008","volume":"116","author":"MR Movahed","year":"2023","unstructured":"Movahed MR, Timmerman B, Hashemzadeh M. Independent association of aortic stenosis with many known cardiovascular risk factors and many inflammatory diseases. Arch Cardiovasc Dis. 2023;116(10):467\u201373.","journal-title":"Arch Cardiovasc Dis"},{"issue":"28","key":"6269_CR7","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1093\/eurheartj\/ehx140","volume":"38","author":"SC Larsson","year":"2017","unstructured":"Larsson SC, Wolk A, H\u00e5kansson N, B\u00e4ck M. Overall and abdominal obesity and incident aortic valve stenosis: two prospective cohort studies. Eur Heart J. 2017;38(28):2192\u20137.","journal-title":"Eur Heart J"},{"issue":"2","key":"6269_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jacc.2019.10.050","volume":"75","author":"M Kaltoft","year":"2020","unstructured":"Kaltoft M, Langsted A, Nordestgaard BG. Obesity as a Causal Risk Factor for Aortic Valve Stenosis. J Am Coll Cardiol. 2020;75(2):163\u201376.","journal-title":"J Am Coll Cardiol"},{"key":"6269_CR9","doi-asserted-by":"crossref","unstructured":"Praz F, Borger MA, Lanz J, Marin-Cuartas M, Abreu A, et al. 2025 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2025;46(44):4635-4736.","DOI":"10.1093\/ejcts\/ezaf393"},{"issue":"20","key":"6269_CR10","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1161\/CIRCULATIONAHA.108.834614","volume":"119","author":"JD Miller","year":"2009","unstructured":"Miller JD, Weiss RM, Serrano KM, Brooks RM 2nd, Berry CJ, Zimmerman K, et al. Lowering plasma cholesterol levels halts progression of aortic valve disease in mice. Circulation. 2009;119(20):2693\u2013701.","journal-title":"Circulation"},{"key":"6269_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.atherosclerosis.2018.08.029","volume":"277","author":"KI Cho","year":"2018","unstructured":"Cho KI, Sakuma I, Sohn IS, Jo SH, Koh KK. Inflammatory and metabolic mechanisms underlying the calcific aortic valve disease. Atherosclerosis. 2018;277:60\u20135.","journal-title":"Atherosclerosis"},{"issue":"24","key":"6269_CR12","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","volume":"389","author":"AM Lincoff","year":"2023","unstructured":"Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221\u201332.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"6269_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/jcpt.13230","volume":"45","author":"S Cornell","year":"2020","unstructured":"Cornell S. A review of GLP-1 receptor agonists in type 2 diabetes: A focus on the mechanism of action of once-weekly agents. J Clin Pharm Ther. 2020;45(Suppl 1):17\u201327.","journal-title":"J Clin Pharm Ther"},{"issue":"9","key":"6269_CR14","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1001\/jamainternmed.2024.2525","volume":"184","author":"PJ Rodriguez","year":"2024","unstructured":"Rodriguez PJ, Goodwin Cartwright BM, Gratzl S, Brar R, Baker C, Gluckman TJ, et al. Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity. JAMA Intern Med. 2024;184(9):1056\u201364.","journal-title":"JAMA Intern Med"},{"issue":"8","key":"6269_CR15","doi-asserted-by":"publisher","first-page":"e2427258","DOI":"10.1001\/jamanetworkopen.2024.27258","volume":"7","author":"MH Chuang","year":"2024","unstructured":"Chuang MH, Chen JY, Wang HY, Jiang ZH, Wu VC. Clinical Outcomes of Tirzepatide or GLP-1 Receptor Agonists in Individuals With Type 2 Diabetes. JAMA Netw Open. 2024;7(8):e2427258.","journal-title":"JAMA Netw Open"},{"key":"6269_CR16","doi-asserted-by":"publisher","unstructured":"Singh K, Frishman WH. Beyond Glycemic Control: Glucagon-Like Peptide-1 Receptor Agonists as Potential Modifiers of Aortic Disease. Cardiol Rev. 2025. Epub ahead of print. https:\/\/doi.org\/10.1097\/CRD.0000000000001045.","DOI":"10.1097\/CRD.0000000000001045"},{"issue":"5","key":"6269_CR17","doi-asserted-by":"publisher","first-page":"102489","DOI":"10.1016\/j.cpcardiol.2024.102489","volume":"49","author":"MB Sardar","year":"2024","unstructured":"Sardar MB, Nadeem ZA, Babar M, Tirzepatide. A novel cardiovascular protective agent in type 2 diabetes mellitus and obesity. Curr Probl Cardiol. 2024;49(5):102489.","journal-title":"Curr Probl Cardiol"},{"issue":"4","key":"6269_CR18","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1161\/ATVBAHA.119.313067","volume":"40","author":"PR Goody","year":"2020","unstructured":"Goody PR, Hosen MR, Christmann D, Niepmann ST, Zietzer A, Adam M, et al. Aortic Valve Stenosis: From Basic Mechanisms to Novel Therapeutic Targets. Arterioscler Thromb Vasc Biol. 2020;40(4):885\u2013900.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl 1","key":"6269_CR19","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.4103\/sja.SJA_543_18","volume":"13","author":"S Cuschieri","year":"2019","unstructured":"Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13(Suppl 1):S31\u20134.","journal-title":"Saudi J Anaesth"},{"issue":"1","key":"6269_CR20","doi-asserted-by":"publisher","first-page":"4471","DOI":"10.1038\/s41467-025-59616-2","volume":"16","author":"YM Lin","year":"2025","unstructured":"Lin YM, Liao KM, Yu T, Wu JY, Lai CC. Effectiveness of tirzepatide in patients with HFpEF using a target trial emulation retrospective cohort study. Nat Commun. 2025;16(1):4471.","journal-title":"Nat Commun"},{"issue":"3","key":"6269_CR21","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.chest.2025.03.030","volume":"168","author":"JY Wu","year":"2025","unstructured":"Wu JY, Chen CC, Ling Tu W, Hsu WH, Liu TH, Tsai YW, et al. Clinical Impact of Tirzepatide on Patients With OSA and Obesity. Chest. 2025;168(3):785\u201396.","journal-title":"Chest"},{"issue":"15","key":"6269_CR22","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1001\/jama.2015.13480","volume":"314","author":"JS Haukoos","year":"2015","unstructured":"Haukoos JS, Lewis RJ. The Propensity Score. JAMA. 2015;314(15):1637\u20138.","journal-title":"JAMA"},{"key":"6269_CR23","doi-asserted-by":"publisher","first-page":"112083","DOI":"10.1016\/j.diabres.2025.112083","volume":"222","author":"JY Wu","year":"2025","unstructured":"Wu JY, Tu WL, Yu T, Liao KM, Lin YM. Tirzepatide and major adverse limb events: Insights from a multicenter real-world analysis in PAD and diabetes patients. Diabetes Res Clin Pract. 2025;222:112083.","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"6269_CR24","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1111\/dom.16353","volume":"27","author":"JY Wu","year":"2025","unstructured":"Wu JY, Chan SE, Hsu WH, Kuo CC, Tsai YW, Liu TH, et al. Comparing clinical outcomes of adults with obesity receiving tirzepatide versus bariatric metabolic surgery: A multi-institutional propensity score-matched study. Diabetes Obes Metab. 2025;27(6):3357\u201366.","journal-title":"Diabetes Obes Metab"},{"key":"6269_CR25","doi-asserted-by":"publisher","first-page":"112279","DOI":"10.1016\/j.diabres.2025.112279","volume":"225","author":"JY Wu","year":"2025","unstructured":"Wu JY, Tseng KJ, Kao CL, Hung KC, Yu T, Lin YM. Clinical effectiveness of tirzepatide for patients with atrial fibrillation and type 2 diabetes: A retrospective cohort study. Diabetes Res Clin Pract. 2025;225:112279.","journal-title":"Diabetes Res Clin Pract"},{"key":"6269_CR26","doi-asserted-by":"crossref","unstructured":"Wu JY, Lin YM, Hsu WH, Liu TH, Tsai YW et al. Comparative effectiveness of tirzepatide versus bariatric metabolic surgery in adults with metabolic-associated steatotic liver disease and obesity: a multi-institutional propensity score-matched study. Hepatol Int. 2025;19(5):1087-1097.","DOI":"10.1007\/s12072-025-10857-9"},{"key":"6269_CR27","doi-asserted-by":"publisher","first-page":"112294","DOI":"10.1016\/j.diabres.2025.112294","volume":"226","author":"JY Wu","year":"2025","unstructured":"Wu JY, Lin YM, Hsu WH, Liu TH, Tsai YW, Huang PY, et al. Comparative clinical outcomes of adults with obstructive sleep apnea and comorbid obesity receiving tirzepatide versus bariatric metabolic surgery: A Multi-Institutional propensity score matched study. Diabetes Res Clin Pract. 2025;226:112294.","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"6269_CR28","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele TJ, Ding P. Sensitivity Analysis in Observational Research: Introducing the E-Value. Ann Intern Med. 2017;167(4):268\u201374.","journal-title":"Ann Intern Med"},{"issue":"20","key":"6269_CR29","doi-asserted-by":"publisher","first-page":"e034891","DOI":"10.1161\/JAHA.123.034891","volume":"13","author":"S Kontogeorgos","year":"2024","unstructured":"Kontogeorgos S, Rosengren A, Sandstr\u00f6m TZ, Fu M, Lindgren M, Basic C, et al. Association Between Body Mass Index and Risk of Aortic Stenosis in Women in the Swedish Medical Birth Registry. J Am Heart Assoc. 2024;13(20):e034891.","journal-title":"J Am Heart Assoc"},{"issue":"13","key":"6269_CR30","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","volume":"359","author":"AB Rosseb\u00f8","year":"2008","unstructured":"Rosseb\u00f8 AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008;359(13):1343\u201356.","journal-title":"N Engl J Med"},{"issue":"23","key":"6269_CR31","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1056\/NEJMoa043876","volume":"352","author":"SJ Cowell","year":"2005","unstructured":"Cowell SJ, Newby DE, Prescott RJ, Bloomfield P, Reid J, Northridge DB, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med. 2005;352(23):2389\u201397.","journal-title":"N Engl J Med"},{"issue":"2","key":"6269_CR32","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1161\/CIRCULATIONAHA.109.900027","volume":"121","author":"KL Chan","year":"2010","unstructured":"Chan KL, Teo K, Dumesnil JG, Ni A, Tam J. Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation. 2010;121(2):306\u201314.","journal-title":"Circulation"},{"key":"6269_CR33","doi-asserted-by":"crossref","unstructured":"Chen SY, Wu JY, Liao KM, Lin YM. Prognostic benefit of glucagon-like peptide-1 receptor agonists addition to sodium-glucose cotransporter 2 inhibitors in patients with atherosclerotic cardiovascular disease and heart failure: a cohort study. Eur Heart J Cardiovasc Pharmacother. 2025;11(4):324-333.","DOI":"10.1093\/ehjcvp\/pvaf014"},{"issue":"2","key":"6269_CR34","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/ehjcvp\/pvae093","volume":"11","author":"YM Lin","year":"2025","unstructured":"Lin YM, Wu JY, Lee MC, Su CL, Toh HS, Chang WT, et al. Comparative cardiovascular effectiveness of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in atherosclerotic cardiovascular disease phenotypes: a systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2025;11(2):174\u201389.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"6","key":"6269_CR35","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s13300-025-01728-5","volume":"16","author":"B Osumili","year":"2025","unstructured":"Osumili B, Sapin H, Yang Z, Ranta K, Paik JS, Bl\u00fcher M. Efficacy and Safety of Tirzepatide Compared with GLP-1 RAs in Patients with Type 2 Diabetes Treated with Basal Insulin: A Network Meta-analysis. Diabetes Ther. 2025;16(6):1279\u2013311.","journal-title":"Diabetes Ther"},{"issue":"1","key":"6269_CR36","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12933-022-01604-7","volume":"21","author":"MA Nauck","year":"2022","unstructured":"Nauck MA, D\u2019Alessio DA. Tirzepatide, a dual GIP\/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction. Cardiovasc Diabetol. 2022;21(1):169.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"6269_CR37","doi-asserted-by":"publisher","first-page":"17896","DOI":"10.1038\/s41598-019-54359-9","volume":"9","author":"C Liu","year":"2019","unstructured":"Liu C, Li G, Laukkanen JA, Hao L, Zhao Q, Zhang J, et al. Overweight and obesity are associated with cardiac adverse structure remodeling in Chinese elderly with hypertension. Sci Rep. 2019;9(1):17896.","journal-title":"Sci Rep"},{"issue":"1","key":"6269_CR38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.12997\/jla.2021.10.1.8","volume":"10","author":"TS Larsen","year":"2021","unstructured":"Larsen TS, Jansen KM. Impact of Obesity-Related Inflammation on Cardiac Metabolism and Function. J Lipid Atheroscler. 2021;10(1):8\u201323.","journal-title":"J Lipid Atheroscler"},{"issue":"2","key":"6269_CR39","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s11010-024-05066-1","volume":"480","author":"Y Yang","year":"2025","unstructured":"Yang Y, Wang Y, Zhou Y, Deng J, Wu L. Tirzepatide alleviates oxidative stress and inflammation in diabetic nephropathy via IL-17 signaling pathway. Mol Cell Biochem. 2025;480(2):1241\u201354.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"6269_CR40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4110\/in.2016.16.1.26","volume":"16","author":"SH Lee","year":"2016","unstructured":"Lee SH, Choi JH. Involvement of Immune Cell Network in Aortic Valve Stenosis: Communication between Valvular Interstitial Cells and Immune Cells. Immune Netw. 2016;16(1):26\u201332.","journal-title":"Immune Netw"},{"issue":"5","key":"6269_CR41","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1182\/bloodadvances.2018025817","volume":"3","author":"R Varshney","year":"2019","unstructured":"Varshney R, Murphy B, Woolington S, Ghafoory S, Chen S, Robison T, et al. Inactivation of platelet-derived TGF-\u03b21 attenuates aortic stenosis progression in a robust murine model. Blood Adv. 2019;3(5):777\u201388.","journal-title":"Blood Adv"},{"issue":"7","key":"6269_CR42","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1210\/en.2018-00336","volume":"159","author":"Y Mori","year":"2018","unstructured":"Mori Y, Kushima H, Koshibu M, Saito T, Hiromura M, Kohashi K, et al. Glucose-Dependent Insulinotropic Polypeptide Suppresses Peripheral Arterial Remodeling in Male Mice. Endocrinology. 2018;159(7):2717\u201332.","journal-title":"Endocrinology"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06269-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06269-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06269-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:32:42Z","timestamp":1790922762000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06269-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6269"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06269-8","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"13 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted using de-identified data from the TriNetX research network. The requirement for informed consent was waived, as the study involved only anonymized patient records and no direct patient intervention. The study was conducted in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"866"}}